Inflammation Medical Cannabis Studies

A

• addiction (10)

• alzheimers/dementia (14)

• amyotrophic-lateral-sclerosis-als-lou-gehrigs (2)

• antibacterial (6)

• antioxidant (8)

• antiprion (1)

• anxiety (10)

• appetite (4)

• arthritis (4)

• asthma (1)

• attention-deficit-hyperactivity-disorder-adhd (5)

• autism (11)

• autoimmune (3)

B

• batten-disease (6)

• benefits (9)

• breast-cancer (7)

C

• cancer (94)

• cannabidiol-cbd (8)

• cardiovascular (8)

• cb1-receptor (8)

• cb2-receptor (9)

• cellular-function (4)

• cerebral-palsy (1)

• cognition (2)

• colon-cancer (8)

D

• d9-tetrahydrocannabinol-thc (4)

• d9-tetrahydrocannabinolic-acid-thca (1)

• diabetes (4)

• drug-interactions (2)

E

• emesis (6)

• endocannabinoid-system-ecs (45)

• endocrine-system (3)

• epilepsy (30)

F

• fibromyalgia (2)

• fibrosis (1)

G

• gastrointestinal-disease (6)

• general (20)

• glaucoma (1)

• glioblastoma (1)

• glioma (9)

H

• health-care (1)

• hiv (7)

• huntingtons-disease (1)

I

• immune-function (8)

• infant-development (1)

• inflammation (9)

• ischemia (3)

K

• krabbe-disease (4)

L

• liver (2)

• lung-cancer (2)

• lupus (1)

M

• memory (3)

• mental-illness (14)

• migraine (1)

• mitochondria (1)

• multiple-sclerosis (15)

N

• national-institute-on-drug-abuse-nida (1)

• nausea (1)

• nervous-system (4)

• neuro-protective-and-neuro-generative (7)

P

• pain (29)

• pancreatitis (1)

• prostate-cancer (2)

S

• schizophrenia (2)

• skin (1)

• sports (3)

T

• thc (1)

• therapeutic (1)

• traumatic-brain-injury-tbi (1)

• View All (505)
  • Cannabidiol (CBD) and its analogs: A review of their effects on inflammation (2015)

    Until 1963 the structure of the CBD was not completely elucidated, and THC was thought to be the most powerful and active component of cannabis, a belief that was mostly due to its psychoactive effects. Therefore, the therapeutic benefits of CBD were minimized for a long time. This study focuses on the therapeutic and anti-inflammatory benefits of CBD. View study

  • Cannabinoid CB2 receptors in human brain inflammation (2008)

    The anti-inflammatory effects triggered by the activation of CB2 receptor make it an attractive target for the development of new anti-inflammatory therapies. In any case, more research is needed to corroborate the potential utility of cannabinoid-based treatments devoid of unwanted psychoactive effects View study

  • Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation (2008)

    CB2 cannabinoid receptors constitute a physiopathological mechanism for the resolution of inflammation in gastrointestinal disorders, thus being a very promising therapeutic objective. View study

  • CANNABINOID-BASED DRUGS AS ANTI-INFLAMMATORY THERAPEUTICS (2005)

    Drugs derived from cannabis have immunosuppressive and anti-inflammatory properties, and may have great therapeutic utility in chronic diseases. View study

  • Cannabinoids in models of chronic inflammatory conditions (No year)

    In the present study we summarize the work on the effects of non-psychotropic cannabidiol (CBD) and a synthetic acid derived from cannabidiol (HU-320) in animal models of arthritis. The results suggest that the CBD and the HU-320 are promising as possible new anti-inflammatory agents. View study

  • Cannabinoids mediate opposing effects on inflammation-induced intestinal permeability (2011)

    Cannabinoids can modulate intestinal permeability in an in vitro model of inflammation. This study suggests that cannabis-based drugs may be of therapeutic benefit in the treatment of inflammatory bowel disorders associated with abnormal intestinal permeability. View study

  • Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation (2008)

    Cannabinoids promote the induction of the anti-inflammatory process according to this revision. Which is intended to be an update on the issue of the participation of cannabinoids in the inflammation process View study

  • Cannabinomimetic Control of Mast Cell Mediator Release: New Perspective in Chronic Inflammation (2008)

    The purpose of this research was to clarify the emerging role played by cannabinomimetic compounds in the control of mast cell activation. The results gave evidence that cannabinomimetic compounds, including palmitoylethanolamide and its congeners, could represent potential candidates for the treatment of several chronic diseases. View study

  • Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid (2007)

    The results obtained give evidence that the addition of ajulemic acid (AjA) (3-30 M) to macrophages derived from human monocytes in vitro reduces the steady state levels of IL-6 mRNA and the subsequent secretion of IL-6 of cells stimulated with LPS View study